SCHEMBL447071

SCHEMBL447071

[O][S]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2718 0.67
SCHEMBL8012781 0.67
SCHEMBL6191 0.67
SCHEMBL6863659 0.58
SCHEMBL1299417 0.58
SCHEMBL8775791 0.58
SCHEMBL1772684 0.58
SCHEMBL7105821 0.58
Charcoal, Activated SCHEMBL1535100 0.58
SCHEMBL81380 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114789591-A Preparation process of ecological-friendly multilayer co-extrusion packaging bag 江苏玉宇环保新材料有限公司 2022-07-26 CN claimed
EP-2301926-A1 HALOGEN COMPOUND, POLYCYCLIC COMPOUND, AND ORGANIC ELECTROLUMINESCENCE ELEMENT COMPRISING THE POLYCYCLIC COMPOUND Idemitsu Kosan Co., Ltd. (JP) 2011-03-30 EP claimed
US-20080234259-A1 Novel Cannabinoid Receptor Ligands, Pharmaceutical Compositions Containing Them, and Process For Their Preparation GLENMARK PHARMACEUTICALS S.A. (CH) 2008-09-25 US claimed
EP-1716188-A1 CLATHROCHELATES AS OLEFIN POLYMERIZATION CATALYST COMPONENTS Equistar Chemicals, LP (US) 2006-11-02 EP claimed
US-20060106044-A1 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines IDENIX PHARMACEUTICALS INC. (US) 2006-05-18 US claimed
WO-2005082955-A1 CLATHROCHELATES AS OLEFIN POLYMERIZATION CATALYST COMPONENTS EQUISTAR CHEMICALS, LP (US) 2005-09-09 WO claimed
EP-1396491-A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors Novartis AG (CH) 2004-03-10 EP claimed
US-6576763-B1 Stereospecific acylation; viricides for herpes and retroviruses MEDIVIR AB (SE) 2003-06-10 US claimed
EP-0707591-B1 METHYLPHOSPHONIC ACID ESTER, PROCESS FOR PREPARING THE SAME AND ITS USE AVENTIS PHARMA GMBH (DE) 2001-09-26 EP claimed
WO-2000026209-A1 ANTI-INFLAMMATORY 4-PHENYL-5-PYRIMIDINYL-IMIDAZOLES NOVARTIS AG (CH) 2000-05-11 WO claimed
EP-0993456-A1 2-SUBSTITUTED 4,5-DIARYL IMIDAZOLES Novartis AG (CH) 2000-04-19 EP claimed
US-5866700-A Solid-phase synthesis of oligoribonucleotides HOECHST AKTIENGESELLSCHAFT (DE) 1999-02-02 US claimed
WO-1999001449-A1 2-SUBSTITUTED 4,5-DIARYL IMIDAZOLES NOVARTIS AG (CH) 1999-01-14 WO claimed
JP-3210324-A None JP disclosed
CN-114040943-B Resin composition, laminate with resin composition layer, laminate, and electromagnetic wave shielding film 东亚合成株式会社 2024-02-23 CN disclosed
CN-116589390-A Polythiols compound and application thereof 中国科学院长春应用化学研究所 2023-08-15 CN disclosed
EP-0064945-B1 HEAT-POLYMERISABLE COMPOSITIONS CIBA-GEIGY AG (CH) 1985-04-03 EP disclosed
EP-0064945-A1 Heat-polymerisable compositions CIBA-GEIGY AG (CH) 1982-11-17 EP disclosed
EP-0054509-A2 Salt of sulfoxonium as a polymerisation catalyst CIBA-GEIGY AG (CH) 1982-06-23 EP disclosed
US-4286999-A COUPLING TO SURFACTANT RAYBESTOS-MANHATTAN, INC. (US) 1981-09-01 US disclosed